Enhancing the QUAlity and Transparency Of health Research

Website translation help
Navigate this website
Home > Library > Reporting guideline > Data linkage in pharmacoepidemiology: A call for rigorous evaluation and reporting

Search for reporting guidelines

Use your browser's Back button to return to your search results

Data linkage in pharmacoepidemiology: A call for rigorous evaluation and reporting

Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)		 Reporting data linkage for pharmacoepidemiologic studies.
Full bibliographic reference Pratt NL, Mack CD, Meyer AM, Davis KJ, Hammill BG, Hampp C, Setoguchi S, Raman SR, Chun DS, Stürmer T, Lund JL. Data linkage in pharmacoepidemiology: A call for rigorous evaluation and reporting. Pharmacoepidemiol Drug Saf. 2020;29(1):9-17.
Language English
PubMed ID 31736248
Study design Observational studies
Clinical area Pharmaceutical medicine
Applies to the whole report or to individual sections of the report? Data
Record last updated on November 2, 2023

Reporting guidelines for main study types

Translations

Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.

About the Library

For information about Library scope and content, identification of reporting guidelines and inclusion/exclusion criteria please visit About the Library.

Visit our Help page for information about searching for reporting guidelines and for general information about using our website.

Library index